HKHedi-Britt Klotškova

Hedi-Britt Klotškova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hedi-Britt Klotškova has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Author Correction: Blood and tissue correlates of steroid non-response in checkpoint inhibition-induced immune-related adverse events

    by Mick J. M. van Eijs, M. Marlot van der Wal, Hedi-Britt Klotškova, Noël M. M. Dautzenberg, Mark Schuiveling, Rik J. Verheijden, Fiona D. M. van Schaik, Bas Oldenburg, Stefan Nierkens, Femke van Wijk, et al.

  • Open Access

    Blood and tissue correlates of steroid non-response in checkpoint inhibition-induced immune-related adverse events

    by Mick J. M. van Eijs, M. Marlot van der Wal, Hedi-Britt Klotškova, Noël M. M. Dautzenberg, Mark Schuiveling, Rik J. Verheijden, Fiona D. M. van Schaik, Bas Oldenburg, Stefan Nierkens, Femke van Wijk, et al.

    Background High-dose steroids constitute the cornerstone of first-line treatment for immune-related adverse events (irAEs) associated with immune checkpoint inhibitors, but compromise antitumor immunity. A deeper understanding of irAEs and their response to steroids can improve management. Methods Using a multi-omics approach, we investigated blood- and tissue-based correlates of steroid response, focusing on gastro-intestinal irAEs, in the largest cohort to date. Results Here we show clear trends for elevated TC1/TC17 CD8+ T cells and Th1/Th7-associated interleukins before steroid initiation, and persistent (CD8+) T cell activation after initiation of steroids in blood of steroid non-responders. Cross-sectional analysis of colitis tissue suggested lower lymphocyte infiltration within 24 h in steroid responders. Peripheral T cell PD-1 receptor occupancy was unrelated to steroid response. Non-responders’ colitis tissue was enriched with activated CD4+ memory T cells and a pronounced type 1/17 immune response. Conclusions These findings highlight rapid steroid effects on circulating cells and irAE-affected tissue and support that an enhanced type 1/type 17 response may be associated with steroid non-response in irAEs. Validation of these findings in larger cohorts is warranted.